Labshake search
Citations for Lonza :
1 - 50 of 154 citations for Recombinant Mouse Fgfr1 Fc tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2020Quote: ... 20% FCS (Lonza), 2 mM L-Glutamine ...
-
bioRxiv - Genomics 2020Quote: ... 10% FCS (Lonza), 1% antibiotic/antimycotic (Life Technologies ...
-
bioRxiv - Molecular Biology 2020Quote: ... containing 10% FCS (Lonza),2 mM L-Glutamin ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 10% FCS (Lonza), 1% L-glutamine (Sigma) ...
-
bioRxiv - Cell Biology 2019Quote: ... supplemented with 10% FCS (Lonza), 1% L-glutamine (Sigma) ...
-
bioRxiv - Biochemistry 2023Quote: ... Medium containing 5% FCS (Lonza) was used to expand and grow cells in a Cell Factory (6320 cm2 ...
-
bioRxiv - Immunology 2023Quote: ... supplemented with 10% FCS (Lonza), 2 mM L-glutamine ...
-
bioRxiv - Bioengineering 2024Quote: ... and recombinant human insulin 0.5%) (Lonza). Human cervical cancer cell line SiHa from ATCC (ATCC® HTB-35™ ...
-
bioRxiv - Molecular Biology 2023Quote: ... 10% foetal calf serum (FCS, Lonza) and grown at 37°C ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 10% (v/v) FCS (Lonza), 1% (v/v ...
-
bioRxiv - Immunology 2021Quote: ... supplemented with 10% heat-inactivated FCS (Lonza) and 1% 0.5M EDTA (Sigma-Aldrich) ...
-
bioRxiv - Cell Biology 2022Quote: ... 20 % v/v FCS (Lonza, Basel, Switzerland), 2 mM L-Glutamine ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with fetal calf serum (FCS, 3%, Lonza) and HEPES (1.8%) ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with fetal calf serum (FCS, 3%, Lonza) and HEPES (1.8% ...
-
bioRxiv - Cancer Biology 2021Quote: ... supplemented with 10% fetal calf serum (FCS, Lonza), 50 units/mL penicillin and 50 μg/mL streptomycin (P/S ...
-
bioRxiv - Developmental Biology 2020Quote: ... supplemented with 10% fetal calf serum (FCS) (Lonza), 2 mM Sodium pyruvate (Gibco) ...
-
bioRxiv - Immunology 2019Quote: ... in 1% FCS and 20mM HEPES in PBS (Lonza). Samples were dissociated with GentleMACS Octo for 30 minutes homogenising/37°C cycle ...
-
Strong paracrine effects of SASP from senescence-induced severe early-onset COPD-derived fibroblastsbioRxiv - Cell Biology 2023Quote: ... with 10% Fetal Calf Serum (FCS) (Lonza, Basel, Switzerland), L-glutamine (Lonza) ...
-
bioRxiv - Cancer Biology 2020Quote: ... recombinant Cas9 nuclease (IDT) and the 4D-Nucleofector (Lonza) as previously described (Wagenblast et al. ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant insulin (20 μg/mL, Lonza, #BE03-033E20), human recombinant EGF (2 ng/mL ...
-
bioRxiv - Cell Biology 2020Quote: ... supplemented with 20% fetal calf serum (FCS; Lonza Group, Ltd.). Primary human mammary epithelial cells (HuMECs ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 10% heat-inactivated fetal calf serum (FCS, Lonza, Switzerland) and cultured at 37°C and 5% CO2 ...
-
bioRxiv - Molecular Biology 2020Quote: ... and 5% (V/V) FCS (LO CC-3202/6, Lonza) up to 70-75% confluency ...
-
bioRxiv - Microbiology 2021Quote: ... supplemented with 10% (vol/vol) fetal calf serum (FCS; Lonza). All cell lines were grown at 37 °C in 5% CO2 ...
-
bioRxiv - Immunology 2020Quote: ... supplemented with 10% FCS and 2 mM glutamine (Lonza, BE17-605F). For lentivirus production ...
-
bioRxiv - Biophysics 2023Quote: ... with or without 10% fetal calf serum (FCS, Lonza, Basel, Switzerland) in a 37°C incubator with 5% CO2 ...
-
bioRxiv - Cell Biology 2022Quote: U2OS cells stably expressing GFP-tagged paxillin were cultured in phenol-red free DMEM (Lonza) at 37°C and 5% CO2 ...
-
bioRxiv - Immunology 2021Quote: ... supplemented with 10% Foetal Calf Serum (FCS) (PAA,, AT or Lonza, CH), 100U/mL penicillin (Sigma-Alrdich ...
-
bioRxiv - Bioengineering 2020Quote: ... Primary (Lifeline: FC-0049) and Human Lung Microvascular Endothelial Cells (Lonza: CC-2527) were grown in T-75 culture flasks in an atmosphere of 5% CO2 at 37°C according to the instructions provide by the manufacturers ...
-
bioRxiv - Cancer Biology 2020Quote: ... The recombinant plasmid was transfected into HT29 cells using 4D-Nucleofecor (Lonza).
-
bioRxiv - Biophysics 2020Quote: ... hydrocortisone and recombinant human epidermal growth factor (MEGM Bullet Kit CC-4136; Lonza). Cells were maintained in an incubator under standard conditions (36.5 °C ...
-
bioRxiv - Bioengineering 2023Quote: The PyroGene Recombinant Factor C Endpoint Fluorescent Assay (Lonza, Walkersville, MD, cat # 50-658U) was performed as recommended ...
-
bioRxiv - Microbiology 2021Quote: ... were electroporated with 1 μg of Ssp1-linearized pcDNA4/TO Strep- tagged ADAP1 or GFP vector using Nucleofector2b (Lonza). Positive clones were selected with 10 μg/mL Blasticidin and 100 μg/mL Zeocin ...
-
bioRxiv - Molecular Biology 2020Quote: ... MBP-tagged TRIM21 (pFastBac-MBP-TRIM21) was expressed in SF9 insect cells in Lonza Insect-XPRESS according to standard protocols (Lonza). Cleared cell lysates were prepared by sonication of cell pellets in 50 mM Tris pH 8 ...
-
bioRxiv - Cell Biology 2023Quote: ... and 2000 p mol of a degron-tagged control protein (mTagBFP2-RxxG) in a 100 µl nucleofection reaction (4D nucleofector kit SE plus supplement SF1, Lonza) 14 hours following nucleofection ...
-
bioRxiv - Cell Biology 2021Quote: ... U2OS and vinculin-/- MEFs were cultured in Dulbecco’s modified Eagles medium (DMEM) supplemented with 10% FCS (Lonza), 1% L-glutamine (Sigma) ...
-
bioRxiv - Cell Biology 2019Quote: NIH3T3s and vinculin-/-MEFs were cultured in Dulbecco’s modified Eagles medium (DMEM) supplemented with 10% FCS (Lonza), 1% L-glutamine (Sigma) ...
-
bioRxiv - Immunology 2022Quote: ... Absence of endotoxins (< 1EU/mL) was confirmed using the PyroGene™ Recombinant Factor C Assay (Lonza) according to manufacturer’s instructions.
-
bioRxiv - Biochemistry 2020Quote: ... supplemented with 6.6 % FCS and 33 % EBM™-2 Endothelial Cell Growth Basal Medium-2 (Lonza, Basel, Switzerland). HELA cells (DSMZ ACC-57 ...
-
bioRxiv - Genetics 2021Quote: ... RNPs containing recombinant CRISPR/Cas9 and sgRNA were transfected to human cell lines using a Nucleofector (Lonza). Stable cell lines were generated by selection of hygrogmycin resistance ...
-
bioRxiv - Molecular Biology 2020Quote: ... Days 16-24 media contained recombinant Oncostatin M (20ng/ml, Thermo) in HCM media lacking EGF (Lonza).
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... 100 μg/ml streptomycin and 15 ng/ml recombinant human macrophage colony stimulating factor (Lonza, Melbourne, Australia) on 10 mm square dishes (Bio-strategy ...
-
bioRxiv - Cell Biology 2023Quote: ... sgRNA and recombinant CAS9 were delivered as ribonucleoprotein (RNP) complexes using a 4D-Nucleofector X-Unit (Lonza). Briefly ...
-
bioRxiv - Neuroscience 2021Quote: ... the reaction was stopped by adding deactivated fetal calf serum (FCS; HyClone) and basic medium (1 % Penicillin/ Streptomycin (Lonza), 10 % FCS ...
-
bioRxiv - Immunology 2021Quote: ... washed in PBS by centrifugation for 5 min at 1300 rpm at 4°C and resuspended at 4.0 × 106 cells/ml in complete medium (IMDM 2 mM glutamax I supplemented with 8% heat-inactivated FCS (Lonza), 2% heat-inactivated chicken serum ...
-
bioRxiv - Cell Biology 2019Quote: ... Recombinant plasmids were verified by Sanger sequencing and electroporated into E14 cells using the Nucleofector II platform (Lonza) (program A-013) ...
-
bioRxiv - Immunology 2021Quote: ... The remaining tissue was minced and digested with stirring for 60 min in complete RPMI (RPMI1640; Lonza; supplemented with 10% fetal calf serum (FCS, 1% Pen/Strep; Lonza) containing 0.25 mg/ml Liberase TL (Roche ...
-
bioRxiv - Immunology 2021Quote: ... Cells were plated at 2 x 106 cells and cultured in RPMI with 10% FCS with low endotoxin levels (Lonza). After 14 d ...
-
bioRxiv - Biochemistry 2021Quote: ... 100 μg ml−1 streptomycin and 15 ng ml−1 recombinant human macrophage colony stimulating factor (Lonza, Melbourne, Australia) on 10 mm square dishes (Bio-strategy ...
-
bioRxiv - Bioengineering 2023Quote: ... gRNAs were complexed with recombinant Cas9 (IDT Cat#1081059) and introduced into cells by electroporation (4D-Nucleofector, Lonza Biosciences) according to manufacturer protocols ...